drugset / Trial / NCT06115967
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants
RandomizedSequentialTriple-blindTreatment
Summary
This study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses of AZD6912 administered subcutaneously (SC) in healthy participants.
Timeline
- Start
- 2023-11-15
- Primary completion
- 2025-10-16
- Completion
- 2025-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD6912 | Unknown | — | Subcutaneous |